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INTRODUCTION
Life-threatening infectious diseases during the course of infection in otherwise healthy individuals can result from single-gene inborn errors of immunity (1, 2) . Mendelian susceptibility to mycobacterial disease (MSMD) is characterized by severe disease upon exposure to weakly virulent mycobacteria, such as Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccines and environmental mycobacteria (3, 4) . Affected patients are also at risk of severe infections with Mycobacterium tuberculosis (MTB), Salmonella, and, more rarely, other intramacrophagic bacteria, fungi, and parasites (4) . All known genetic etiologies of MSMD affect interferon- (IFN-)-mediated immunity (4, 5) .
The most common etiology of MSMD is autosomal recessive (AR) interleukin-12 receptor 1 (IL-12R1) deficiency, which has been reported in more than 200 kindreds since 1998 and has probably been diagnosed in many more (4, (6) (7) (8) (9) . IL-12R1 deficiency displays incomplete clinical penetrance for MSMD and can also underlie salmonellosis (10) or tuberculosis in families with no history of infection with environmental mycobacteria or BCG (4, 8, 11) . IL-12R1 dimerizes with IL-12R2 to form the IL-12 receptor (12) or with IL-23R to form the IL-23 receptor (13) . IL12B encodes the p40 subunit common to both IL-12 (with p35) and IL-23 (with p19) (14) . AR IL-12p40 deficiency, which has been reported in more than 50 kindreds, is a clinical phenocopy of IL-12R1 deficiency (4, 15) .
Both IL-12 immunity and IL-23 immunity are abolished in these two disorders. Unlike other etiologies of MSMD, these two disorders can also underlie chronic mucocutaneous candidiasis (CMC), which is seen in about 25% of patients, due to impaired IL-17A/IL-17F-mediated immunity (6, (16) (17) (18) . All known genetic etiologies of isolated or syndromic CMC affect IL-17A/IL-17F (17, (19) (20) (21) (22) (23) . Studies of mouse models have suggested that disruption of the IL-12-IFN- circuit, particularly in CD4 + T helper 1 (T H 1) cells, underlies mycobacteriosis in these patients, whereas disruption of the IL-23-IL-17 circuit, particularly in T H 17 cells, underlies candidiasis (14) . However, the respective contributions of human IL-12 and IL-23 to IFN--dependent MSMD and IL-17A/IL-17F-dependent CMC have remained elusive in the absence of inborn errors of IL-12p35, IL-12R2, IL23p19, or IL-23R. 0   1000   2000   3000   4000   76   76   31   76   76   31   76   76   31   76   76   31   pSTAT4   STAT4   GAPDH   pSTAT3   STAT3   GAPDH   IL-12  IFN-α   NT  EV  WT  Q138X  WT  C115Y   IL-12Rβ2  IL-23R   IL-23  IFN-α   NT  EV  WT  Q138X  WT  C115Y   IL-12Rβ2  IL-23R   H  I   pSTAT4   STAT4   GAPDH   pSTAT3   STAT3   GAPDH   HVS-T  EBV-B   IL-12 IFN-α S3 , A to C). There are also fewer homozygous missense variants for these three genes (Fig. 2 , C and D, and fig. S3D ). Overall, this computational study suggested that neither IL12RB2 nor IL23R had evolved under purifying selection, or even under strong negative selection, and that they were no less mutated than IL12RB1 in the general population. These findings support the alternative hypothesis that the paucity of MSMD patients with IL-12R2 or IL-23R deficiency, relative to the number of patients identified with IL-12R1 deficiency, results from lower clinical penetrance for MSMD.
Rarity of null mutations in IL12RB1, IL12RB2, and IL23R
We tested these computational predictions through experimental determinations of the actual frequency of IL12RB2 and IL23R LOF mutations in the general population, by using the same retroviral system to express all previously untested variants of both genes present in the homozygous state in gnomAD ( (Fig. 2E) . The L130S mutation of IL12RB2 was found to be present in the homozygous state in 1 of 123,092 individuals in the gnomAD database. The IL12RB2 K649N mutation affects a splice site and may, therefore, cause a missense or splicing mutation, resulting in the deletion of exon 15 (ex15) (fig. S3, H and I). The IL12RB2 K649N mutation was found to encode a protein that was both expressed (fig. S3G) and functional ( Fig. 2E) , such as the WT protein, whereas the IL12RB2 ex15 mutation encoded a protein with a lower molecular weight ( fig. S3G ) that was nonfunctional (Fig. 2E ). The IL12RB2 K649N mutation was identified in 1 of 138,539 individuals in the gnomAD database. None of the IL23R mutations tested resulted in a complete loss of protein expression or function ( Fig. 2F and fig. S3J ). These and previous data (35) suggest that homozygous complete LOF mutations of IL12RB2, IL23R, and IL12RB1 occur in the general population at a frequency of <1 in 100,000 individuals. This frequency is similar to that of AR IL-12R1 deficiency, the penetrance of which for MSMD reaches a plateau of about 80% in adults (6, 7).
In vivo T H development in IL-12R2 and IL-23R deficiency
As a first approach to testing the hypothesis that IL-12R2 and IL-23R deficiencies have a lower clinical penetrance for MSMD than IL-12R1 deficiency, we set out to decipher the cellular basis of MSMD in patients with these disorders. In humans and mice, IL-12 and IL-23 are thought to promote mutually exclusive CD4 + T H cell fates (14) . Before testing for IL-12-and IL-23-dependent effects on the differentiation of human T H cells, we compared the frequencies of leukocyte subsets in peripheral blood mononuclear cells (PBMCs) of healthy controls, an IL12RB2 Q138X patient, an IL23R C115Y patient, and cells were left nontransduced (NT) or were transduced with retroviruses generated with an empty vector or vectors containing V5-tagged WT or mutant versions of IL12RB2, including the 16 mutations indicated. These IL12RB2 mutations are present in at least one individual in the gnomAD database. Cells were left unstimulated or were stimulated with IL-12 or IFN-. Cell lysates were prepared, and Western blotting was performed with antibodies against pSTAT4, total STAT4, and GAPDH. (F) LCL-B
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cells were left nontransduced (NT) or were transduced with retroviruses generated with an empty vector or vectors containing V5-tagged WT or mutant versions of IL23R for the 14 mutations indicated. With the exception of the C115Y mutation found in kindred B, these IL23R mutations are each present in at least one individual in the gnomAD database. Cells were left unstimulated or were stimulated with IL-23 or IFN-. Cell lysates were prepared, and Western blotting was performed with antibodies against pSTAT3, total STAT3, and GAPDH. (fig. S4A ), consistent with previous findings for IL-12R1-and STAT3-deficient patients (36) . The frequency of naïve cells in the CD4 + and CD8 + T cell populations was higher, and that of memory cells was lower in IL-12R2-, IL-23R-, and IL-12R1-deficient patients than in healthy controls (Fig. 3A, left panel, and  fig. S4, B and C (Fig. 3A, right panel) . However, within the CD4 + memory compartment, the percentages of T H 1* and T H 17 cells were low in some IL-12R1-deficient patients, but not in IL-12R2-or IL-23R-deficient patients, whereas T H 1 and T H 2 percentages were normal in patients of all genotypes ( fig. S4D ). These unexpected findings suggested that isolated deficiencies of IL-12 or IL-23 responses had similar and slightly milder consequences, in terms of T H 1, T H 1*, and perhaps T H 17 development, than a combined deficiency.
In vitro T H differentiation in IL-12R2 and IL-23R deficiency
We then investigated the effects of IL-12 and IL-23 signaling defects on the generation of CD4 + T cell subsets upon stimulation with polarizing cytokines in vitro. Naïve (CD45RA + CCR7 + ) CD4 + T cells from PBMCs from healthy donors and from IL-12R2-, IL-23R-, and IL-12R1-deficient patients were purified and cultured under T H 0 (nonpolarizing) or T H 1-, T H 2-, or T H 17-polarizing conditions (37) , and the production of various cytokines was measured in culture supernatants with cytometric bead arrays or by enzyme-linked immunosorbent assay (ELISA). T H 1 differentiation in vitro, which occurs in the presence of IL-12 and is assessed by monitoring IFN- production, was abolished in cells from IL-12R2-and IL-12R1-deficient patients but was intact in IL-23R-deficient patient cells (Fig. 3B ). By contrast, T H 17 differentiation in vitro in the presence of IL-23, as assessed by monitoring IL-17F production, was maintained in IL-12R2-deficient cells but abolished in naïve CD4 + T cells from IL-23R-and IL-12R1-deficient patients (Fig. 3B) . After T H 2 differentiation in vitro, which occurs in the presence of IL-4, cells of all genotypes produced similar amounts of IL-10 (Fig. 3B) . The interpretation of these data is limited by the small number of individuals discovered to date with isolated deficiencies of IL-12R2 or IL-23R. However, these preliminary data suggest that the cytokine-dependent in vitro differentiation of naïve CD4 + T cells into T H 1 and T H 17 cells is affected by IL-12R2 deficiency and IL-23R deficiency, respectively, consistent with previous findings (14) . We probed genotype-dependent effects on the generation of cytokine-producing CD4 + T cells in vivo further by purifying naïve (CD45RA (37) . As expected, IL-12R1-and IL-23R-deficient cell cultures displayed only low levels of IL-17A and IL-17F production (Fig. 3C) . Similar amounts of IL-10 were again produced by all cells tested. The production of IFN-, tumor necrosis factor (TNF), and IL-2 by memory CD4 + T cells was reduced not only by IL-12R1 or IL-12R2 deficiency but also by IL-23R deficiency, possibly due to T cell-intrinsic functional defects or to the low frequency of T H 1 and/or T H 1* cells in the three groups of patients.
Compromised production of Mycobacterium-specific IFN- in T H cells
We assessed the potential effects of deficiencies of IL-12R1, IL-12R2, or IL-23R on the induction of Mycobacterium-specific CD4 + T cell responses in vivo by analyzing memory CD4 + T cells from healthy controls and patients of each genotype (38) . Both BCG-vaccinated and BCGunvaccinated individuals have been shown to robustly produce IFN- in response to BCG (39) and mycobacteria-derived antigens (40) . Multiple T cell lines were generated from sorted CD4 (42) . In the same experiment, the production of IL-4 was not affected by any of the mutations tested ( fig. S6A ). All T cell lines were then screened in vitro for recall responses to influenza virus, respiratory syncytial virus (RSV), BCG, and MTB. Several T cell lines from both healthy donors and patients proliferated in response to the antigens tested ( fig.  S6B ). As expected, the frequency of influenza-and RSV-reactive cells was higher in CCR6 − T cell lines, whereas the frequency of BCG-and MTBreactive cells was higher in CCR6 + T cell lines. (fig. S6 , B and C). No major differences in the frequency of precursor cells specific for the tested antigens ( fig. S6C) were observed, but genotype-dependent defects were observed in the production of cytokines by proliferating T cells. The production of IFN-, but not of IL-4, by influenza virus-or RSV-reactive CCR6 − T cells was impaired in IL-12R2-and IL-12R1-deficient patients, but not in IL-23R-deficient patients ( fig. S6D ). The levels of IFN- production by BCG-and MTB-responding CCR6 + T cells were low in IL-12R1-, IL-12R2-, and IL-23R-deficient patients (Fig. 4A, left panels) . IL-17A was produced by only a few healthy donor CCR6 + T cells in response to BCG and MTB, precluding comparisons between genotypes (Fig. 4A) . In the same cells, IL-22 production was low in IL-12R1-and IL-23R-deficient patients, but not in IL-12R2-deficient patients (Fig. 4A) , providing further evidence of a functional IL-23R deficiency. However, the role of human IL-22 in immunity to infection remains undetermined. CD4 + T cells from Il23a −/− mice showed severely defective IL-17 and IL-22 production, mildly reduced IFN- production, and increased mycobacterial growth, when compared with WT mice after MTB infection (43) . Yet, Il17ra −/− and Il22 −/− mice did not differ from WT mice in their control of MTB growth (43), unlike Ifng −/− mice (44), suggesting that IL-23-dependent IFN- production is involved in this setting. Other studies have shown that IL-23 augments local IFN- production in the lung and limits pulmonary MTB replication in mice (45) . Overall, these data indicate that, in the absence of either IL-12 or IL-23 signaling, Mycobacterium-specific IFN- production is compromised in CCR6 + memory CD4 + T H 1* cells, a cellular phenotype common to inherited retinoic acid-related orphan receptor (ROR)-/T (37) and signal peptide peptidase-like 2a (SPPL2a) deficiencies (46). (47) . BCG or environmental mycobacterial disease of genetic origin in patients without isolated or syndromic MSMD has been documented only in patients with severe combined immunodeficiency (SCID), who lack all types of endogenous T cells (48) . Although some SCID patients lack NK cells in addition to T cells, isolated NK cell deficiency does not confer a predisposition to mycobacterial disease (49) (50) (51) . We therefore assessed mRNA levels for IL12RB1, IL12RB2, and IL23R in various leukocyte subsets and assessed the consequences of IL-12 and IL-23 signaling in each of these cell types. Human IL12RB1 mRNA production has been reported in many types of human leukocytes, the lowest levels being reported in B cells and monocytes and the highest levels in NK cells (52) . IL12RB2 and IL23R display a high degree of sequence identity and probably arose through gene duplication (13), but they nevertheless have different patterns of expression, with IL12RB2 mRNA levels highest in  T cells and NK cells, whereas IL23R mRNA levels are highest in  T cells and only moderate in CD4
+ and CD8 +  T cells (52) . We confirmed these findings ( fig. S7A ) and stimulated purified B cells, CD4
+  T cells, CD8 +  T cells,  T cells, and NK cells from healthy donors with IL-12 or IL-23 for 6 hours, before assessing the genome-wide transcriptional consequences by mRNA microarray analysis. Cytokine-and cell type-specific patterns were observed. Notably, IFNG transcripts were the most consistently induced across cell types and stimuli (Fig. 4, C and D) . This result was validated by quantitative polymerase chain reaction (qPCR) (Fig. 4E) and ELISA for IFN- on cell culture supernatants (Fig. 4F) . We expanded this study to include MAIT cells, NKT cells, and ILCs, all of which have been reported to be potent IFN- producers [reviewed in (53, 54) ]. MAIT cells and NKT cells clearly responded to each cytokine by producing IFN-, but they responded more strongly to IL-23 (Fig. 4, G and H) . ILC1 and ILC2 isolated from peripheral blood responded to IL-12, but not to IL-23, by producing IFN- (Fig. 4I) . ILC3 isolated from tonsillar tissue responded to either IL-23 or IL-12 by producing IFN- (Fig. 4I) . Last, the stimulation of PBMCs from healthy donors or IL-12R1-deficient patients with M. bovis BCG, together with IL-12 or IL-23, revealed that IL-12 strongly potentiated the IFN- response to BCG but that IL-23 also increased IFN- production, albeit to a lesser extent ( fig. S7, B to D) .
Collectively, these data demonstrate that different cell types (including but not limited to CD4 + T cells) produce different amounts of IFN- in response to IL-12 versus IL-23, explaining why both cytokines are individually, and even much more so collectively, important to antimycobacterial immunity.
DISCUSSION
Collectively, these data shed light on the respective contributions of IL-12 and IL-23 to human immunity to Mycobacterium and Candida through the discovery and characterization of AR complete IL-12R2 and IL-23R deficiencies in two multiplex MSMD kindreds without CMC. The unexpected absence of CMC in IL-23R-deficient P4 and P5, as in most patients with complete IL-12R1 deficiency, may be due to the incomplete penetrance of IL-23 deficiency for poor IL-17A/ IL-17F production, incomplete penetrance of low levels of IL-17 production for CMC, IL-23-independent mechanisms of IL-17 production, or a combination of these. All known forms of isolated or syndromic CMC disrupt IL-17A/IL-17F immunity (17, (19) (20) (21) (22) (23) (table S2) . Clinically, these results add IL12RB2 and IL23R to the list of 11 other genes (IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1 , NEMO, CYBB, IRF8, ISG15, TYK2, and SPPL2A) mutated in MSMD patients, the products of which are all involved in IFN--mediated immunity (4, 5, 37) . Patients with deleterious mutations in IL17F, IL17RC, IL17RA, or ACT1 have CMC without mycobacterial disease (17, (19) (20) (21) (22) (23) . Our results therefore reveal that both IL-12-and IL-23-dependent signaling pathways play critical roles in human antimycobacterial immunity via the induction of IFN-. Our findings show that human IL-12 and IL-23 are partly, but not totally, redundant with each other for IFN--dependent antimycobacterial immunity. These findings in natural conditions in humans corroborate and extend previous experiments performed in mice (43, 45) .
IL-12-and IL-23-dependent induction of IFN- may occur either within the same cell type or differentially across different cell types, and IL-23 may provoke IFN- by direct or indirect means (which may include processes dependent on and independent of IL-17 and IL-22). The absence of response to both these molecules, as in patients with complete IL-12R1 deficiency, underlies MSMD with incomplete but high penetrance, reaching an estimated 65% by 5 years of age and 80% in adults (4). It was not possible to calculate the penetrance of IL-12R2 and IL-23 deficiencies, but the data from our population and family genetic studies strongly suggest that penetrance is much lower in both these deficiencies, accounting for the diagnosis of IL-12R1 deficiency in a hundred times as many kindreds to date. This notion is strongly supported by our accompanying report that as many as 1 of 600 Europeans homozygous for TYK2 P1104A has normal responses to IL-12 and impaired responses to IL-23, rendering them vulnerable to tuberculosis and, more rarely, to MSMD (55) . The primary, essential function of both IL-12 and IL-23 in humans is to induce IFN- and control mycobacteria and other intramacrophagic pathogens, perhaps due to the duplication of the loci encoding both these cytokines and their receptors. The contribution of IL-23 to IL-17 antifungal immunity is more modest and may be more recent in terms of evolution, as both the IL-23R-deficient patients described here and most IL-12R1-deficient patients described to date are not susceptible to Candida.
MATERIALS AND METHODS

Study design
We studied five patients with MSMD or tuberculosis from two unrelated kindreds. We analyzed these two kindreds independently by a combination of WES and GWL. In patients P1 to P3 (kindred A), we found a homozygous mutation resulting in the premature stop codon Q138X in IL-12R2. In patients P4 and P5 (kindred B), we found a homozygous mutation resulting in the missense C115Y substitution in the extracellular domain of IL-23R. We examined the consequences of these mutations both in isogenic overexpression experiments and in the patients' cells. We found that the IL-12R2 Q138X and IL-23R C115Y mutations abolish cellular responses to IL-12 and IL-23, respectively. We analyzed the frequency of IL-12R2 and IL-23R deficiencies in the general population. We characterized the leukocyte subsets that produce IFN- in response to IL-12 versus IL-23.
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